Moreover, demonstrating the causal role of chemerin in obesity-induced hypertension requires further studies and in vivo inhibition of chemerin levels in A-NOS3 KO mice is needed to confirm the pathological role of the augmented chemerin level. The gene discussed is RARRES2; the disease is obesity disorder.